To assess whether, in a lung resection cohort with a low probability of confounding by indication, higher FiO2 is associated with an increased risk of impaired postoperative oxygenation - a clinical manifestation of lung injury/dysfunction. Pre-specified registry-based retrospective cohort study. Two large academic hospitals in the United States. 2936 lung resection patients with an overall good intraoperative oxygenation (median intraoperative SpO2≥95%). We compared patients with a higher (≥0.8) and lower (<0.8) median intraoperative FiO2 after propensity score-weighting for 75 perioperative variables based on a causal inference framework. The primary outcome of impaired oxygenation was defined as at least one of the following within seven postoperative days: (1) SpO2<92%; (2) imputed PaO2/FiO2<300mmHg [(1) or (2) at least twice within 24h]; (3) intensive oxygen therapy (mechanical ventilation or>50% oxygen or high-flow oxygen). Among the 2936 included patients, 2171 (73.8%) received median intraoperative FiO2≥0.8. Impaired postoperative oxygenation occurred in 1627 (74.9%) and 422 (55.2%) patients in the higher and lower FiO2 groups, respectively. In a propensity score-weighted analysis, higher intraoperative FiO2 was associated with an 84% increase in the likelihood of impaired postoperative oxygenation (OR 1.84; 95% CI 1.60 to 2.12; P<0.001). Despite plausible harm from hyperoxia, high intraoperative FiO2 is extremely common during lung resection. Nearly three-quarters of lung resection patients with acceptable oxygenation received median intraoperative FiO2≥0.8. Such higher FiO2 was associated with an increased risk of impaired postoperative oxygenation - a clinically relevant manifestation of lung injury or dysfunction. This observation supports the administration of a lower (< 0.8) intraoperative FiO2 and its further assessment in clinical trials.
Read full abstract